文章基本信息

标题：Effects of the Revised Reimbursement Guideline for Anti-Osteoporosis Medication in South Korea
本地全文：下载
作者：Young-Seung Ko ; Yeonsuk Jeong ; Jung-Wee Park 等
期刊名称：Journal of Bone Metabolism
印刷版ISSN：2287-6375
出版年度：2022
卷号：29
期号：3
页码：191-196
DOI：10.11005/jbm.2022.29.3.191
语种：English
出版社：The Korean Society for Bone and Mineral Research
摘要：Background The Korean National Health Insurance (NHI) reimbursement guideline was revised in May 2015 with the aim of preventing secondary osteoporotic fractures. Here we compared the: (1) rate of bone mineral density (BMD) measurements; (2) prescription rate of anti-osteoporosis medication within 3 months after hip fracture surgery (HFS); (3) incidence of a second hip fracture; and (4) first-year mortality rate after HFS. Methods This before-after study used the revised reimbursement system as a reference period. We retrospectively reviewed the medical records of 515 patients who underwent HFS at a tertiary referral hospital between January 2014 and December 2016. The period 1 group underwent HFS in 2014, while the period 2 group underwent HFS in 2016. Results Despite the fact that there was no significant intergroup difference in BMD measurement rate, the period 2 group had a higher prescription rate for anti-osteoporosis drugs within 3 months of HFS. However, the incidence of a second hip fracture did not differ between groups. The first-year mortality rate was higher in the period 1 versus period 2 group. Conclusions Revision of the NHI guideline in May 2015 was associated with an increased prescription rate of anti-osteoporosis medication in osteoporotic hip fracture patients.
关键词：Hip fractures;Mortality;Osteoporosis